NovaBay Total Other Income Expense Net vs Total Operating Expenses Analysis

NBY Stock  USD 0.13  0.01  7.50%   
NovaBay Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NovaBay Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NovaBay Pharmaceuticals is a good investment. Please check the relationship between NovaBay Pharmaceuticals Total Other Income Expense Net and its Total Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Total Other Income Expense Net vs Total Operating Expenses

Total Other Income Expense Net vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NovaBay Pharmaceuticals Total Other Income Expense Net account and Total Operating Expenses. At this time, the significance of the direction appears to have very week relationship.
The correlation between NovaBay Pharmaceuticals' Total Other Income Expense Net and Total Operating Expenses is 0.23. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of NovaBay Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NovaBay Pharmaceuticals' Total Other Income Expense Net and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of NovaBay Pharmaceuticals are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Total Other Income Expense Net i.e., NovaBay Pharmaceuticals' Total Other Income Expense Net and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.23
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Other Income Expense Net

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from NovaBay Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NovaBay Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.At this time, NovaBay Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 18.2 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit5.6M7.8M7.9M8.1M
Total Revenue8.4M14.4M14.7M10.0M

NovaBay Pharmaceuticals fundamental ratios Correlations

0.83-0.370.10.340.450.160.170.33-0.61-0.25-0.160.730.640.630.50.00.370.870.590.30.23-0.110.12-0.19-0.05
0.83-0.110.020.13-0.110.02-0.20.28-0.76-0.04-0.40.790.340.740.540.020.290.880.620.330.20.06-0.21-0.29-0.24
-0.37-0.110.130.05-0.49-0.49-0.45-0.230.25-0.09-0.56-0.31-0.02-0.38-0.33-0.66-0.15-0.39-0.3-0.180.380.550.07-0.07-0.48
0.10.020.130.760.04-0.50.230.450.48-0.750.0-0.20.23-0.390.29-0.170.56-0.15-0.170.730.79-0.07-0.2-0.040.12
0.340.130.050.760.34-0.130.590.390.31-0.990.04-0.070.44-0.340.33-0.320.510.030.120.460.64-0.06-0.240.18-0.03
0.45-0.11-0.490.040.340.310.630.120.06-0.340.370.050.6-0.030.05-0.020.20.160.1-0.060.03-0.290.570.150.26
0.160.02-0.49-0.5-0.130.310.44-0.27-0.450.140.320.36-0.260.35-0.150.31-0.360.370.04-0.34-0.52-0.22-0.140.26-0.04
0.17-0.2-0.450.230.590.630.440.320.24-0.610.25-0.060.09-0.190.060.040.290.060.00.08-0.08-0.18-0.190.650.35
0.330.28-0.230.450.390.12-0.270.320.14-0.37-0.040.10.270.130.45-0.130.950.210.380.750.44-0.17-0.190.020.45
-0.61-0.760.250.480.310.06-0.450.240.14-0.390.22-0.910.0-0.93-0.35-0.290.21-0.86-0.490.190.270.160.080.240.12
-0.25-0.04-0.09-0.75-0.99-0.340.14-0.61-0.37-0.39-0.060.16-0.430.42-0.290.35-0.510.06-0.08-0.42-0.630.050.21-0.220.03
-0.16-0.4-0.560.00.040.370.320.25-0.040.22-0.06-0.240.05-0.230.180.480.03-0.290.140.09-0.04-0.650.13-0.220.24
0.730.79-0.31-0.2-0.070.050.36-0.060.1-0.910.16-0.240.050.920.450.190.00.910.490.01-0.04-0.32-0.13-0.250.14
0.640.34-0.020.230.440.6-0.260.090.270.0-0.430.050.05-0.030.34-0.340.490.210.460.230.490.020.57-0.29-0.18
0.630.74-0.38-0.39-0.34-0.030.35-0.190.13-0.930.42-0.230.92-0.030.370.290.00.890.45-0.01-0.22-0.27-0.08-0.250.16
0.50.54-0.330.290.330.05-0.150.060.45-0.35-0.290.180.450.340.370.40.520.420.760.420.33-0.48-0.25-0.30.24
0.00.02-0.66-0.17-0.32-0.020.310.04-0.13-0.290.350.480.19-0.340.290.4-0.190.180.190.04-0.45-0.38-0.240.020.24
0.370.29-0.150.560.510.2-0.360.290.950.21-0.510.030.00.490.00.52-0.190.150.40.780.59-0.12-0.07-0.050.28
0.870.88-0.39-0.150.030.160.370.060.21-0.860.06-0.290.910.210.890.420.180.150.510.15-0.07-0.1-0.14-0.08-0.02
0.590.62-0.3-0.170.120.10.040.00.38-0.49-0.080.140.490.460.450.760.190.40.510.190.09-0.28-0.08-0.310.02
0.30.33-0.180.730.46-0.06-0.340.080.750.19-0.420.090.010.23-0.010.420.040.780.150.190.64-0.08-0.28-0.220.1
0.230.20.380.790.640.03-0.52-0.080.440.27-0.63-0.04-0.040.49-0.220.33-0.450.59-0.070.090.64-0.110.09-0.46-0.06
-0.110.060.55-0.07-0.06-0.29-0.22-0.18-0.170.160.05-0.65-0.320.02-0.27-0.48-0.38-0.12-0.1-0.28-0.08-0.11-0.010.41-0.67
0.12-0.210.07-0.2-0.240.57-0.14-0.19-0.190.080.210.13-0.130.57-0.08-0.25-0.24-0.07-0.14-0.08-0.280.09-0.01-0.30.0
-0.19-0.29-0.07-0.040.180.150.260.650.020.24-0.22-0.22-0.25-0.29-0.25-0.30.02-0.05-0.08-0.31-0.22-0.460.41-0.30.03
-0.05-0.24-0.480.12-0.030.26-0.040.350.450.120.030.240.14-0.180.160.240.240.28-0.020.020.1-0.06-0.670.00.03
Click cells to compare fundamentals

NovaBay Pharmaceuticals Account Relationship Matchups

NovaBay Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.2M15.2M24.0M16.4M9.0M14.4M
Total Stockholder Equity973K12.3M10.2M10.6M3.3M5.3M
Other Assets477K912K476K489K562.4K461.6K
Common Stock Shares Outstanding618.3K1.0M1.2M1.6M4.2M4.4M
Liabilities And Stockholders Equity11.2M15.2M24.0M16.4M9.0M14.4M
Other Stockholder Equity125.7M148.0M150.9M165.1M176.4M185.2M
Total Liab10.2M2.9M13.8M5.8M5.7M7.1M
Other Current Liab993K1.4M803K917K570K541.5K
Total Current Liabilities5.7M2.8M3.4M4.3M4.3M4.1M
Property Plant And Equipment Net1.4M520K604K2.0M1.4M1.0M
Net Debt(2.9M)(11.4M)(7.0M)(3.3M)(390K)(409.5K)
Retained Earnings(125.0M)(136.1M)(141.9M)(158.2M)(174.8M)(166.1M)
Accounts Payable331K302K1.0M1.1M1.1M812.7K
Cash6.9M12.0M7.5M5.4M3.1M6.0M
Non Current Assets Total1.8M996K10.8M5.1M1.9M2.0M
Cash And Short Term Investments6.9M12.0M7.5M5.4M3.1M3.0M
Common Stock Total Equity154K171K279K418K480.7K263.6K
Other Current Assets105K102K144K113K388K271.6K
Property Plant And Equipment Gross1.4M520K1.2M2.6M2.1M1.1M
Total Current Assets9.4M14.2M13.2M11.3M7.2M9.5M
Accumulated Other Comprehensive Income(243K)(509K)(560K)(275K)(247.5K)(259.9K)
Common Stock279K418K478K652K112K106.4K
Property Plant Equipment110K520K604K2.0M1.8M1.8M
Other Liab2.5M560K4.1M10.1M11.6M12.2M
Current Deferred Revenue822K730K1.3M1.8M946K1.2M
Non Current Liabilities Total4.6M87K10.4M1.6M1.4M2.6M
Short Term Debt3.5M416K305K453K1.6M1.7M
Non Currrent Assets Other77K2K476K489K21K20.0K
Net Receivables1.1M1.1M1.7M2.0M759K721.1K
Net Tangible Assets5.0M973K12.3M(237K)(213.3K)(202.6K)
Retained Earnings Total Equity(111.1M)(115.0M)(125.0M)(136.1M)(122.5M)(116.3M)
Capital Surpluse125.7M148.0M150.9M165.1M189.8M118.8M
Inventory492K608K3.2M3.4M2.9M3.0M
Non Current Liabilities Other198K4.6M561K334K300.6K285.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether NovaBay Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NovaBay Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novabay Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novabay Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for NovaBay Stock analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Revenue Per Share
3.494
Quarterly Revenue Growth
0.023
Return On Assets
(0.25)
Return On Equity
(1.39)
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.